期刊
THORAX
卷 74, 期 10, 页码 965-976出版社
BMJ PUBLISHING GROUP
DOI: 10.1136/thoraxjnl-2019-213037
关键词
lung cancer; cystic fibrosis; pneumonia; asthma; copd pharmacology
资金
- Science Foundation Ireland (SFI)
- Health Research Board (HRB)
- Science Foundation Ireland (SFI) under the AMBER Centre Directors Fund project [12565]
Nanomedicine is a multidisciplinary research field with an integration of traditional sciences such as chemistry, physics, biology and materials science. The application of nanomedicine for lung diseases as a relatively new area of interdisciplinary science has grown rapidly over the last 10 years. Promising research outcomes suggest that nanomedicine will revolutionise the practice of medicine, through the development of new approaches in therapeutic agent delivery, vaccine development and nanotechnology-based medical detections. Nano-based approaches in the diagnosis and treatment of lung diseases will, in the not too distant future, change the way we practise medicine. This review will focus on the current trends and developments in the clinical translation of nanomedicine for lung diseases, such as in the areas of lung cancer, cystic fibrosis, asthma, bacterial infections and COPD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据